Literature DB >> 31179309

Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.

Sabine Weiskirchen1, Philipp Kim1, Ralf Weiskirchen1.   

Abstract

Copper (Cu) is an essential trace element that is vital to the health of all living organisms. As a transition metal, it is involved in a myriad of biological processes. Balance studies estimated that the adult human requirement for copper is in the range of 1.3 to 2 mg per day. Cu deficiency alters immune function, neuropeptide synthesis and antioxidant defense, while the excess in Cu results in oxidative stress and progressive structural damage of mitochondrial and clinically in hepatic and/or neurological symptoms. This becomes particularly visible in Wilson's disease (WD) representing a rare autosomal recessive inherited disorder with a disease prevalence of about 1 in 30,000 people. The affected gene, i.e., ATP7B, belongs to the class of ATP-dependent, P-type Cu-transporting ATPases. To understand the pathomechanism in WD, several experimental models for studying WD were established. Independent studies performed in these models showed that the inactivation of the Atp7b gene results in a gradual increase in Cu in many organs during life span. However, the exact distribution of Cu and the potential impact of elevated Cu concentrations on other metals within the tissue are only sparely analyzed. Recently, novel laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)-based protocols for metal bio-imaging in liver and brain were established. In the present review, we will discuss the methodological background of this innovative technique and summarize our experiences using LA-ICP-MS imaging in biological monitoring, exact measurement, and spatial assignment of metals within tissue obtained from Atp7b null mice and clinical specimens taken from patients suffering from genetically confirmed WD. Using WD as an example, the data discussed demonstrates that LA-ICP-MS has multi-element capability, allowing precise measurement and visualization of metals in the tissue with high spatial resolution, sensitivity, quantification ability, and exceptional reproducibility.

Entities:  

Keywords:  Atp7b; Wilson’s disease (WD); animal experimentation; excel-based laser-ablation imaging (ELAI); imaging; metal overload

Year:  2019        PMID: 31179309      PMCID: PMC6531650          DOI: 10.21037/atm.2018.10.67

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  58 in total

1.  TISSUE COPPER PROTEINS IN WILSON'S DISEASE. INTRACELLULAR DISTRIBUTION AND CHROMATOGRAPHIC FRACTIONATION.

Authors:  H PORTER
Journal:  Arch Neurol       Date:  1964-10

2.  Chronological changes in tissue copper, zinc and iron in the toxic milk mouse and effects of copper loading.

Authors:  Katrina J Allen; Nicole E Buck; Daphne M Y Cheah; Sophie Gazeas; Prithi Bhathal; Julian F B Mercer
Journal:  Biometals       Date:  2006-10       Impact factor: 2.949

3.  A new strain of rat for functional analysis of PINA.

Authors:  Samreen Ahmed; Jie Deng; Jimo Borjigin
Journal:  Brain Res Mol Brain Res       Date:  2005-03-31

4.  Iron accumulation in the liver of male patients with Wilson's disease.

Authors:  Y Shiono; S Wakusawa; H Hayashi; T Takikawa; M Yano; T Okada; H Mabuchi; S Kono; H Miyajima
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.

Authors:  O I Buiakova; J Xu; S Lutsenko; S Zeitlin; K Das; S Das; B M Ross; C Mekios; I H Scheinberg; T C Gilliam
Journal:  Hum Mol Genet       Date:  1999-09       Impact factor: 6.150

6.  Chances and shortcomins of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats.

Authors:  D Ha-Hao; U Merle; C Hofmann; H Wesch; J Doll; G Auburger; S Tuma; M Strauss; W Stremmel
Journal:  Z Gastroenterol       Date:  2002-04       Impact factor: 2.000

7.  Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease.

Authors:  Harmeet Malhi; Adil N Irani; Irene Volenberg; Michael L Schilsky; Sanjeev Gupta
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

8.  Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease.

Authors:  Peter Ferenci; Petra Steindl-Munda; Wolfgang Vogel; Wolfgang Jessner; Michael Gschwantler; Rudolf Stauber; Christian Datz; Franz Hackl; Fritz Wrba; Peter Bauer; Oskar Lorenz
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

9.  Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64.

Authors:  C J EARL; M J MOULTON; B SELVERSTONE
Journal:  Am J Med       Date:  1954-08       Impact factor: 4.965

Review 10.  Diagnosis and phenotypic classification of Wilson disease.

Authors:  Peter Ferenci; Karel Caca; Georgios Loudianos; Georgina Mieli-Vergani; Stuart Tanner; Irmin Sternlieb; Michael Schilsky; Diane Cox; Frieder Berr
Journal:  Liver Int       Date:  2003-06       Impact factor: 5.828

View more
  2 in total

1.  Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plasma Mass Spectrometry.

Authors:  Philipp Kim; Chengcheng Christine Zhang; Sven Thoröe-Boveleth; Sabine Weiskirchen; Nadine Therese Gaisa; Eva Miriam Buhl; Wolfgang Stremmel; Uta Merle; Ralf Weiskirchen
Journal:  Biomedicines       Date:  2020-09-16

2.  Analyzing the Therapeutic Efficacy of Bis-Choline-Tetrathiomolybdate in the Atp7b-/- Copper Overload Mouse Model.

Authors:  Philipp Kim; Chengcheng Christine Zhang; Sven Thoröe-Boveleth; Eva Miriam Buhl; Sabine Weiskirchen; Wolfgang Stremmel; Uta Merle; Ralf Weiskirchen
Journal:  Biomedicines       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.